Archive for the 'Gadolinium' Category

18 May

Pfizer Settles Neurontin Death Related Suit Before Trial

The world’s largest drugmaker, Pfizer, was set to defend itself today in court regarding a wrongful-death lawsuit alleging its Neurontin epilepsy medicine caused a retired minister to commit suicide two months after he began taking the drug for chronic pain, not epilepsy. However, attorneys for the New York-based firm told a Nashville, Tennessee judge they [...]

06 May

Positive News for Omniscan Patients

Omniscan plaintiffs were bolstered by U.S. District Judge Dan Polster’s recent decision regarding their lawsuits. In a 58-page procedural ruling, the judge restricted key parts of GE Healthcare’s case, but said most of the plaintiffs’ expert witnesses will be allowed to testify at trials. GE Healthcare tried to exclude many plaintiff’ theories and witnesses from [...]

19 Apr

Omniscan Restriction Advised, But Not Heeded, Four Years Ago

Four years ago, GE Healthcare experts recommended limiting the use of their gadolinium contrast dye, Omniscan, after it was linked to nephrogenic systemic fibrosis (NSF), reveals ProPublica. The decision was fueled by European reports that tied Omniscan to a likely crippling disease that is now known as NSF. Meeting details were exposed in a lawsuit’s [...]

09 Dec

Covidien’s Optimart and General Electric’s Omniscan Considered Risky

Thickening of the skin, organs and other tissues, broken bones, and difficulty moving the body are associated with a potentially fatal skin disease called nephrogenic systemic fibrosis (NSF).  Some gadolinium contrast dyes used for MRI scans could be the cause, according to a Food & Drug Administration (FDA) advisory panel. Finally, the FDA is taking [...]

To Get Help Now
Gadolinium
Click Here